Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Revenue by Business
Cygnus$66.22M+5.5%$65.96M+5.0%$65.35M+2.9%$64.25M+0.5%$62.78M-3.1%
TriLink$138.51M-22.7%$119.79M-39.0%$127.09M-40.4%$155.58M-26.1%$179.08M-14.5%
Restructuring by Business
Cygnus$37.5K$54K
TriLink$12.5M$13.82M
Other Restructuring Costs by Business
Cygnus$2.25K$3K
TriLink$284.25K$379K
Asset Impairments by Business
Corporate$2.89M$3.86M
Cygnus$0$0
TriLink$8.72M$10.82M
Severance Costs by Business
Cygnus$35.25K$51K
TriLink$1.52M$2.62M
Revenue by Geography
Asia Pacific$38.79M-50.8%$41.47M-53.6%$48.96M-47.7%$63.54M-33.3%$78.8M-11.7%
Europe, the Middle East and Africa$45.99M+16.2%$30.92M-26.5%$30.92M-38.8%$34.32M-26.7%$39.57M-21.3%
Latin and Central America$1.15M+130%$971K+46.7%$756K+6.9%$585K-14.8%$501K-26.4%
North America$118.8M-3.4%$112.38M-11.6%$111.8M-15.3%$121.39M-7.9%$122.99M-8.2%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How does Maravai LifeSciences Holdings, Inc. break its business down?
Maravai LifeSciences Holdings, Inc. (MRVI) reports revenue by business across 2 parts — Cygnus and TriLink. Each is extracted from the segment footnotes and tracked over time.
Where does Maravai LifeSciences Holdings, Inc.'s segment data come from?
Segment breakdowns are pulled from the segment footnotes in Maravai LifeSciences Holdings, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.